SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-05-09 09:55
Tx date 2022-05-04
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,000
+20,000 vol
$0.30 each
1,169,125
Filed 2022-04-22 11:49
Tx date 2022-04-18
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-93,210
-300,000 vol
$0.3107 each
1,149,125
Filed 2022-04-22 11:41
Tx date 2022-04-22
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
$114,280
+571,400 vol
$0.20 each
2,745,025
Filed 2022-04-22 11:36
Tx date 2022-04-22
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Convertible Debentures
11 - Acquisition or disposition carried out privately
$
+$100 vol
$1,000 each
$100
Filed 2022-04-22 11:35
Tx date 2019-11-26
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-21 22:05
Tx date 2022-02-28
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$71,489
+420,528 vol
$0.17 each
1,808,928
Filed 2022-03-01 09:57
Tx date 2022-02-28
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$75,884
+446,381 vol
$0.17 each
Filed 2022-03-01 09:57
Tx date 2022-02-28
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$75,884
+446,381 vol
$0.17 each
1,834,781
Filed 2022-02-28 20:36
Tx date 2022-02-28
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+700,000 vol
2,173,625
Filed 2022-02-28 20:31
Tx date 2022-02-28
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$98,000
+700,000 vol
$0.14 each
1,449,125
Filed 2021-12-03 11:53
Tx date 2021-12-03
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$675.00
+5,000 vol
$0.135 each
749,125
Filed 2021-12-03 11:52
Tx date 2021-12-03
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$700.00
+5,000 vol
$0.14 each
744,125
Filed 2021-08-03 23:15
Tx date 2021-08-03
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,300
+20,000 vol
$0.215 each
739,125
Filed 2021-05-15 10:22
Tx date 2021-05-10
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+50,000 vol
1,473,625
Filed 2021-05-15 10:19
Tx date 2021-05-10
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$17,500
+50,000 vol
$0.35 each
719,125
Filed 2021-05-15 09:50
Tx date 2021-05-10
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$17,500
+50,000 vol
$0.35 each
Filed 2021-05-15 09:50
Tx date 2021-05-10
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$17,500
+50,000 vol
$0.35 each
719,125
Filed 2021-05-15 09:49
Tx date 2021-05-10
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-13,160
-47,000 vol
$0.28 each
669,125
Filed 2021-03-23 23:31
Tx date 2021-03-22
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

-172,500 vol
716,125
Filed 2021-03-23 23:24
Tx date 2021-03-22
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+172,500 vol
Filed 2021-01-11 09:53
Tx date 2021-01-08
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,650
+15,000 vol
$0.51 each
888,625
Filed 2021-01-04 18:18
Tx date 2020-12-31
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+1,388,400 vol
1,388,400
Filed 2021-01-04 18:15
Tx date 2019-11-26
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-01-04 18:07
Tx date 2020-12-31
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
$21,000
+70,000 vol
$0.30 each
1,423,625
Filed 2021-01-04 18:05
Tx date 2020-12-31
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation

-25,718,875 vol
1,353,625
Filed 2021-01-04 17:59
Tx date 2020-12-31
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$21,000
+70,000 vol
$0.30 each
873,625
Filed 2021-01-04 17:58
Tx date 2020-12-31
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-15,268,875 vol
803,625
Filed 2021-01-04 17:49
Tx date 2020-12-31
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

+803,625 vol
Filed 2021-01-04 17:09
Tx date 2020-12-31
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

+803,625 vol
Filed 2021-01-04 16:39
Tx date 2020-12-31
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$21,000
+70,000 vol
$0.30 each
Filed 2021-01-04 16:38
Tx date 2020-12-31
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
$21,000
+70,000 vol
$0.30 each
Filed 2020-12-31 16:47
Tx date 2020-12-31
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
$21,000
+70,000 vol
$0.30 each
Filed 2020-12-31 15:40
Tx date 2020-12-31
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$21,000
+70,000 vol
$0.30 each
Filed 2020-12-31 16:47
Tx date 2020-12-31
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
$21,000
+70,000 vol
$0.30 each
27,142,500
Filed 2020-12-31 15:40
Tx date 2020-12-31
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$21,000
+70,000 vol
$0.30 each
16,142,500
Filed 2020-12-31 15:39
Tx date 2020-12-29
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-66,000
-2,200,000 vol
$0.03 each
16,072,500
Filed 2020-12-18 17:44
Tx date 2020-12-18
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+10,000,000 vol
27,072,500
Filed 2020-12-18 17:29
Tx date 2020-12-18
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$100,000
+10,000,000 vol
$0.01 each
18,272,500
Filed 2020-12-18 17:27
Tx date 2020-12-18
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$100,000
+10,000,000 vol
$0.01 each
Filed 2020-12-06 11:38
Tx date 2020-12-05
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$100,000
+10,000,000 vol
$0.01 each
Filed 2020-12-06 11:30
Tx date 2020-12-05
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$100,000
+10,000,000 vol
$0.01 each
Filed 2020-12-06 11:23
Tx date 2020-12-03
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-100,000
-10,000,000 vol
$0.01 each
8,272,500
Filed 2020-05-28 21:55
Tx date 2020-05-28
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+13,472,500 vol
17,072,500
Filed 2020-05-28 21:50
Tx date 2020-05-28
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$1,815,082,562,500
+13,472,500 vol
$134,725 each
18,272,500
Filed 2020-03-10 12:29
Tx date 2019-11-26
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
3,600,000
Filed 2020-03-10 12:25
Tx date 2020-03-05
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$129,600,000,000
+3,600,000 vol
$36,000 each
4,800,000
Filed 2020-03-10 12:22
Tx date 2019-11-26
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Units 1 common share plus 1 common share purchase warrant
00 - Opening Balance-Initial SEDI Report
Filed 2020-03-10 12:19
Tx date 2019-11-26
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Units 1 common share plus 1 common share purchase warrant
00 - Opening Balance-Initial SEDI Report
Filed 2019-12-09 19:19
Tx date 2019-12-04
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,000
+500,000 vol
$0.01 each
1,200,000
Filed 2019-12-03 17:12
Tx date 2019-11-26
$HEM
Hemostemix Inc.
Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
700,000
Filed 2019-07-12 15:23
Tx date 2019-07-12
$SDR
Stroud Resources Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,500,000,000
+500,000 vol
$5,000 each
500,000
Filed 2019-07-12 15:21
Tx date 2019-06-14
$SDR
Stroud Resources Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-08
Tx date 2018-05-01
$BRD
Broadway Gold Mining Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Units
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-08
Tx date 2018-05-01
$BRD
Broadway Gold Mining Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
75,000
Filed 2019-03-08
Tx date 2018-05-01
$BRD
Broadway Gold Mining Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-08
Tx date 2018-05-01
$BRD
Broadway Gold Mining Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Units
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-06
Tx date 2018-05-01
$BRD
Broadway Gold Mining Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Units
00 - Opening Balance-Initial SEDI Report
150,000
Filed 2019-03-05
Tx date 2019-03-01
$BRD
Broadway Gold Mining Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$10,500
+150,000 vol
$0.07 each
650,000
Filed 2018-09-05
Tx date 2018-08-01
$BRD
Broadway Gold Mining Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Options incentive stock options
50 - Grant of options

+300,000 vol
800,000
Filed 2018-09-04
Tx date 2018-08-31
$BRD
Broadway Gold Mining Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Options incentive stock options
50 - Grant of options
$20,000
+100,000 vol
$0.20 each
600,000
Filed 2018-08-29
Tx date 2018-08-22
$BRD
Broadway Gold Mining Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$80,000
+400,000 vol
$0.20 each
Filed 2018-08-29
Tx date 2018-08-22
$BRD
Broadway Gold Mining Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$80,000
+400,000 vol
$0.20 each
Filed 2018-08-29
Tx date 2018-05-01
$BRD
Broadway Gold Mining Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Options incentive stock options
00 - Opening Balance-Initial SEDI Report
500,000
Filed 2018-08-22
Tx date 2018-08-22
$BRD
Broadway Gold Mining Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
50 - Grant of options
$80,000
+400,000 vol
$0.20 each
900,000
Filed 2018-08-22
Tx date 2018-08-22
$BRD
Broadway Gold Mining Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$25,000
+250,000 vol
$0.10 each
500,000
Filed 2018-07-30
Tx date 2018-07-30
$BRD
Broadway Gold Mining Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$25,000
+250,000 vol
$0.10 each
250,000
Filed 2018-07-30
Tx date 2018-05-01
$BRD
Broadway Gold Mining Ltd.
Smeenk, Thomas
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report